NextCure Inc (NASDAQ:NXTC)
| 1.75 Delayed Data As of May 26 |  0.00 / 0.00%Today’s Change | 1.16 Today|||52-Week Range 5.27 | +24.11% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $48.2M |
Company Description
NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines. The company was founded by Michael S. Richman and Lie Ping Chen in September 2015 and is headquartered in Beltsville, MD.
Contact Information
NextCure, Inc. 9000 Virginia Manor Road Beltsville Maryland 20705 |
Employees
Shareholders
| Mutual fund holders | 8.62% |
| Other institutional | 20.09% |
| Individual stakeholders | 12.17% |
Top Executives
| Michael S. Richman | President, Chief Executive Officer & Director |
| Timothy Mayer | Chief Operating Officer |
| Steven P. Cobourn | Chief Financial Officer |
| Solomon Langermann | Chief Scientific Officer |
| Han Myint | Chief Medical Officer |
